Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics Revenue

Mersana Therapeutics had revenue of $11.01M in the quarter ending September 30, 2025, a decrease of -12.61%. This brings the company's revenue in the last twelve months to $33.18M, down -4.76% year-over-year. In the year 2024, Mersana Therapeutics had annual revenue of $40.50M with 9.88% growth.

• Revenue (ttm): $33.18M
• Revenue Growth: -4.76%
• P/S Ratio: 4.36
• Revenue / Employee: $325,294
• Employees: 102
• Market Cap: 145.11M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.50M	3.64M	9.88%
Dec 31, 2023	36.86M	10.27M	38.65%
Dec 31, 2022	26.58M	26.54M	61,716.28%
Dec 31, 2021	43.00K	-785.00K	-94.81%
Dec 31, 2020	828.00K	-41.30M	-98.03%
Dec 31, 2019	42.12M	31.53M	297.61%
Dec 31, 2018	10.59M	-6.95M	-39.62%
Dec 31, 2017	17.55M	-7.63M	-30.30%
Dec 31, 2016	25.17M	14.81M	142.99%
Dec 31, 2015	10.36M	-	-